Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoral plus ACE inhibitor vs ACE inhibitor alone in idiopathic membranous nephropathy
2005-004469-40Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Dec 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in membranous glomerulonephritis (MGN) and idiopathic membranous glomerulonephritis (IMG) (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Complete remission at 6 months. Started Dec 2005; status: completed.
02
Drugs
cyclosporine
03
Conditions
membranous glomerulonephritis (MGN)idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on 2005-004469-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004469-40.